共 50 条
- [31] TOLERANCE OF EXTENDED (28-DAY) CONTINUOUS INFUSION OF 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER SELECTIVE CANCER THERAPEUTICS, 1991, 7 (01): : 17 - 21
- [32] COMBINATION CYTOTOXIC EFFECTS OF 5-FLUOROURACIL AND CARBOPLATIN AGAINST HUMAN LUNG-CANCER CELL-LINES CANCER RESEARCH THERAPY & CONTROL, 1995, 4 (03): : 199 - 202
- [34] TREATMENT OF RECURRENT HEAD AND NECK-CANCER WITH CISPLATIN AND 5-FLUOROURACIL VS THE SAME PLUS BLEOMYCIN AND METHOTREXATE LARYNGOSCOPE, 1992, 102 (08): : 901 - 907
- [35] 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 2ND-LINE CHEMOTHERAPY IN HEAD AND NECK-CANCER AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 1 - 3
- [36] RESPONSE TO PREOPERATIVE CONCOMITANT RADIOCHEMOTHERAPY WITH MITOMYCIN-C AND 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05): : 845 - 849
- [38] ALTERNATING CISPLATIN-5-FLUOROURACIL AND RADIOTHERAPY IN HEAD AND NECK-CANCER AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 538 - 542
- [39] MODIFIED 5-FLUOROURACIL (5FU)+ CISPLATINUM (CP) REGIMEN IN ADVANCED SQUAMOUS HEAD AND NECK-CANCER (HNC) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 216 - 216